Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: A multi-center, randomized, double-blind, placebo-controlled trial

Hepato-Gastroenterology

Volumn 45, Issue 21, 1998, Pages 797-804

  Niederau, C ^a,c   Strohmeyer, G ^a   Heintges, T ^a   Peter, K ^b   Gopfert E ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Rhone Poulenc Rorer GmbH   (Germany)

^c St Josef Hospital Oberhausen   (Germany)

Author keywords

Aminotransferases; Phospholipids; Viral hepatitis; Viral replication

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; AMINOTRANSFERASE; ESSENTIALE; HEPATITIS B(E) ANTIGEN; PHOSPHATIDYLCHOLINE; VIRUS DNA; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; FEVER; HEADACHE; HEPATITIS B; HEPATITIS C; HUMAN; INFLUENZA; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENCE RISK; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS REPLICATION; VOMITING;

ADULT; AGED; ALANINE TRANSAMINASE; ANTILIPEMIC AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EVALUATION STUDIES; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON TYPE I, RECOMBINANT; MIDDLE AGED; PHOSPHATIDYLCHOLINES; TIME FACTORS;

EID: 0031874820     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sherlock DE: The management of chronic hepatitis. Curr Opin Gastroenterol 1996; 12:217-223.
2. Niederau C, Heintges T, Lange S et al: Long-term follow-up of HBe-Ag patients treated with Interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334:1422-1427.
3. Poynard T, Bedossa P, Chevallier M et al: A comparison of three Interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332:1457-1462.
4. Lieber CS, Robins SJ, Li J et al: Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994; 106:152-159.
5. Zierenberg O, Grundy SM: Intestinal absorption of polyenylphosphatidyl choline in man. J Lipid Res 1982; 23:1136-1142.
6. Bartsch GG, Gerber GB: Influence of phospholipids on liver damage II. Changes in lipid content and synthesis after liver damage with carbon tetrachloride and other agents. Acta Hepatogastroenterol 1975; 22:228-236.
7. Fuji S, Okuda T, Imagawa T: Effect of polyphosphatidylcholine (PPC) on experimentally induced liver disturbances. Shikoku Acta Med 1974; 30:76-85.
8. Gerber GB, Bartsch GG, Deroo J: Influence of phospholipids on liver damage. I Carbon tetrachloride poisoning and alterations in amino acid uptake, peroxidation, sialic acid content, and lysosomal enzymes, Acta Hepatogastroenterol 1975; 22:175-180.
9. Neuberger J, Hegarty JE, Eddleston ALWF, Williams R: Effect of polyunsaturated phosphatidyl choline on immune mediated hepatocyte damage. Gut 1983; 24:751-755.
10. Shakun NP, Bukhar EI: Effect of anti-oxidants on lipid peroxidation and liver condition in patients with pulmonary tuberculosis. Farmakol Toksikol 1986; 49:112-114.
11. Biagi PL, Bordoni A, Hrelia S, Celadon M, Turchetto E: The effect of dietary polyenylphopshatidylcholine on microsomal delta-6-desaturase activity, fatty acid composition, and microviscosity in rat liver under oxidative stress. J Nutr Biochem 1993; 4:690-94.
12. Barbarino F, Neumann E, Toganel E et al: Effect of "essential" phospholipids in experimental D-galactosamine-induced liver cell damage. Therapiewoche Österreich 1990; 5:415-419.
13. LeKim D, Betzing H: Incorporation of PPC-substance in healthy and galactosamine-damaged rats. Drug Re 1974; 24:1217-1221.
14. Ma X, Zhao J, Lieber CS: Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression. J Hepatol 1996; 24:604-613.
15. Wagener HH, Fomtaine R, Neumann B: Pharmacology of "essential" phospholipids. Drug Res 1976; 26:1733-1743.
16. Holecek M, Mraz J, Koldova P, Skopec F: Effect of polyunsaturated phosphatidylcholine on liver regeneration onset after hepatectomy in the rat. Drug Res 1992; 42:337-694.
17. Stoffel W, Darr W, Assmann G: Pleomorphic functions of highly unsaturated phospholipids in biological membranes and serum lipoproteins. Med Welt 1978; 26:124-131.
18. Schüller-Perez A, Gonzalez-San MF: Kontrollierte Studie mit mehrfach ungesättigtem Phosphatidylcholin im Vergleich zu Plazebo bei alkoholischer Lebersteatose. Med Welt 1985; 36:517-21.
19. Knüchel F: Double-blind study in patients wit alcoholic fatty liver. Med Welt 1979; 30:411-416.
20. Panos MZ, Polson R, Johnson R, Portmann B, William SR: Polyunsaturated phosphatidyl choline for acute alcoholic hepatitis: a double-blind, randomized, placebo-controlled trial. Eur J Gastroenterol Hepatol 1990; 2:351-355.
21. Bird GLA, Panos MZ, Poison R et al: Activity of polyunsaturated phosphatidylcholine in HBsAG negative chronic active hepatitis and acute alcoholic hepatitis. Z Gastroenterol 1991; 29:21-24.
22. Jenkins PJ, Portmann BP, Eddleston ALWF, Williams R: Use of polyunsaturated phosphatidyl choline in HBs-Ag negative chronic active hepatitis: results of a double-blind controlled trial. Liver 1982; 2:77-81.
23. Ilic V: Efficacy of "essential" phospholipids in the treatment of acute and chronic liver disease. Z Gastroenterol 1991; 29:25-29.
24. Lieber CS, DeCarli LM, Mak KM et al: Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 1990; 12:1390-1398.
25. Niederau C, Heintges T, Häussinger D: Dose and duration of Interferon therapy in chronic hepatitis C: an analysis of the literature. Hepato-Gastronenterology 1997; 43:1544-56.
26. Li J-J, Kim C-I, Leo MA et al: Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology 1992; 15:373-381.